RECRUITING

The Effects of Bariatric Surgeries on Glucose Metabolism

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is learn the effect of gastric bypass surgery and sleeve gastrectomy on glucose metabolism mediated by neural and hormonal factors initiated after eating.

Official Title

The Effects of Bariatric Surgeries on Glucose Metabolism

Quick Facts

Study Start:2015-07
Study Completion:2026-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02823665

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Hypoglycemic RYGB patients with documented blood glucose level \<50 mg/dl
  2. * Asymptomatic individuals with bariatric surgery
  3. * Healthy non-surgical patients with no personal history of diabetes
  4. * Subjects must physically be able to come to our clinical research center Cedars-Sinai Medical Center
  1. * Active heart, lung, liver, gastrointestinal or kidney disease; unable to give informed consent; pregnancy; uncontrolled high blood pressure or high cholesterol; significant anemia (hemoglobin \<11g/dL); prisoners or institutionalized individuals; type 2 diabetes mellitis; development of any serious medical or psychiatric illness during recruitment or studies;
  2. * RYGB patients will be disqualified if they have gastric outlet obstruction or severe diarrhea.
  3. * Healthy non-surgical patients with personal history of diabetes
  4. * History of glaucoma
  5. * Uncontrolled hypertension (any subjects with BP\>140/90 and history of dyslipidemia
  6. * Taking any medication that might interact with atropine and cannot be stopped will be excluded from the study)
  7. * Myasthenia gravis
  8. * Brain pathology
  9. * Enlarged prostate in men

Contacts and Locations

Study Contact

Marzieh Salehi, MD MS
CONTACT
210-567-6691
salehi@uthscsa.edu
Andrea Hansis-Diarte
CONTACT
210-567-6691
hansisdiarte@uthscsa.edu

Principal Investigator

Marzieh Salehi, MD, MS
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center at San Antonio

Study Locations (Sites)

Texas Diabetes Institute - University Health System
San Antonio, Texas, 78207
United States
South Texas Veterans Health Care System
San Antonio, Texas, 78229
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center at San Antonio

  • Marzieh Salehi, MD, MS, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center at San Antonio

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-07
Study Completion Date2026-08

Study Record Updates

Study Start Date2015-07
Study Completion Date2026-08

Terms related to this study

Keywords Provided by Researchers

  • gastric bypass surgery
  • Hypoglycemia
  • sleeve gastrectomy
  • glucose tolerance

Additional Relevant MeSH Terms

  • Post Bariatric Surgery
  • Gastric Bypass
  • Sleeve Gastrectomy
  • Hypoglycemia After Gastric Bypass